In addition, in breast cancer, the secretion of miR‐122 vesicles can downregulate GLUT1 and pyruvate kinase (PK) expression and reduce glucose uptake in nontumor cells, thereby increasing premetastatic cell nutrient availability and promoting metastasis.36 The gene discussed is SLC2A1; the disease is breast cancer.